☆ 4.6 Article

Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis

FRONTIERS IN ONCOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Biotechnology & Applied Microbiology

Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations

Anna Vaynrub et al.

Summary: This article reviews the treatment modalities for TGCT, introduces a new drug called pexidartinib for TGCT, and compares its efficacy and safety profile with surgery, radiotherapy, and watchful monitoring. The results show that pexidartinib has shown promising outcomes in improving joint mobility, pain, and recurrence-free survival.

ONCOTARGETS AND THERAPY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer

Limei Zhong et al.

Summary: BRD4 is significantly overexpressed in breast cancer tissues compared to normal tissues, and this high expression is associated with poor overall survival and immune cell infiltration levels in patients with breast cancer, indicating its potential as a prognostic biomarker.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis

Hor-Yue Tan et al.

Summary: LOXL4 plays a role in immune evasion by tumor cells and hepatocarcinogenesis by inducing an immunosuppressive microenvironment. Its interaction with macrophages leads to increased PD-L1 expression and subsequent inhibition of CD8(+) T cell function, promoting tumor growth. The immunosuppressive function of LOXL4 on macrophages primarily relies on interferon-mediated PD-L1 activation.

HEPATOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Targeting immunosuppression by TGF-β1 for cancer immunotherapy

Gregoire de Streel et al.

Summary: TGF-beta 1 serves as a key mediator in various biological processes, but its complex biology and dual roles in cancer progression have hindered therapeutic advancements. Recent successes with immunostimulatory antibodies in cancer immunotherapy, along with targeted therapies against specific sources of TGF-beta activity, offer potential to enhance efficacy and reduce toxicity.

BIOCHEMICAL PHARMACOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma

Stephan Braun et al.

Summary: This review evaluates the clinical role of derazantinib, an investigational FGFR inhibitor, in patients with iCCA harboring actionable FGFR2 genetic aberrations. Derazantinib has shown clinically meaningful efficacy with durable objective responses, supporting its therapeutic potential in previously treated iCCA patients. The safety profile of derazantinib was manageable and compared favorably to other FGFR inhibitors, indicating the need for increased molecular profiling of cholangiocarcinoma patients.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment

Nadia Bolandi et al.

Summary: Gastric cancer is the third leading cause of death globally, despite a stable reduction in its incidence. Poor response to common treatments and late diagnosis make it a lethal cancer. The emerging use of immunotherapy and immune checkpoint inhibitors has changed the landscape of treatment for gastric cancer patients, with the manipulation of signals from the B7 family showing significant potential in management.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Mathematical & Computational Biology

Identification of the active substances and mechanisms of ginger for the treatment of colon cancer based on network pharmacology and molecular docking

Meng-Meng Zhang et al.

Summary: This study used a network pharmacology approach to explore the mechanisms of ginger in preventing colon cancer, finding that ginger exerts preventive effects against colon cancer by regulating multi-targets, multi-pathways, and multi-components. This provides a novel insight for the development of ginger compounds as new drugs for anti-colon cancer.

BIODATA MINING (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Cell Biology

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma

Min He et al.

Summary: Lower expression of CLEC10A in LUAD patients is associated with worse outcomes, and its expression is significantly correlated with various tumor-infiltrating immune cells. Therefore, CLEC10A may be a promising prognostic indicator and immunotherapy target for LUAD.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Add to Collection

Article Oncology

A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy

Miguel F. Sanmamed et al.

Summary: The study has identified a dysfunctional CD8(+) tumor-infiltrating subpopulation that is highly proliferative, overactivated, and apoptotic, distinct from previously described exhausted T cells. This subpopulation expands in lung cancer tissues in a PD-1/B7-H1-dependent manner and its abundance is associated with resistance to cancer immunotherapy, making it a potential tissue biomarker.

CANCER DISCOVERY (2021)

Add to Collection

Review Immunology

Critical Roles of Balanced T Helper 9 Cells and Regulatory T Cells in Allergic Airway Inflammation and Tumor Immunity

Muhua Huang et al.

Summary: CD4(+)T helper (Th) cells play crucial roles in immune responses in asthma and cancer. The balance between Th9 cells and Treg cells is important in regulating allergic airway inflammation and tumor immunity, and dysregulation of this balance may contribute to the development and exacerbation of these diseases.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Add to Collection

Article Genetics & Heredity

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma

Shougang Liu et al.

Summary: This study investigated the expression and prognostic implications of the ERBB family in cutaneous melanoma. It was found that lower expression of ERBB1/2 and higher expression of ERBB3 were associated with poor 5-year survival rates. ERBB2/3 were related to immune cell infiltration in melanoma.

FRONTIERS IN GENETICS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

LOXL2 Inhibitors and Breast Cancer Progression

Sandra Ferreira et al.

Summary: LOX and LOXL2 are amine oxidases that catalyze cross-linking reactions of elastin and collagen in connective tissue, with LOXL2 showing high expression in certain tumors. Inhibition of LOX and LOXL2 is considered a promising strategy for preventing metastasis and invasion of breast cancer. Novel synthetic compounds acting as selective inhibitors for LOX/LOXL2 or dual LOX/LOXL inhibitors have been developed, showing potential for effective therapeutic approaches in breast cancer treatment.

ANTIOXIDANTS (2021)

Add to Collection

Article Cell Biology

Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations

Wei Li et al.

Summary: This study explored genomic and immune cell infiltration profiles among four distinct HCC types, revealing significant differences in gene mutation and CNV level. The study found that total gene CNV level, rather than mutational burden of HCC, is associated with immune cell infiltration in HCC. TP53 mutation may impair immune response in HBV-related HCC.

AGING-US (2021)

Add to Collection

Article Oncology

The impact of socioeconomic status on stage at presentation, receipt of diagnostic imaging, receipt of treatment and overall survival in colorectal cancer patients

Rajan Shah et al.

Summary: The study revealed that colorectal cancer patients with lower socioeconomic status tend to present at later stages, receive less comprehensive treatment, and have poorer overall survival rates. These disparities persist even in a universal healthcare system.

INTERNATIONAL JOURNAL OF CANCER (2021)

Add to Collection

Review Oncology

In Vivo Targeting of CXCR4-New Horizons

Margret Schottelius et al.

Summary: This review focuses on the role of CXCR4 in tumor cell growth and metastasis, as well as its involvement in inflammatory responses. It discusses the current status of CXCR4-targeted imaging in cancer and inflammation, highlighting recent advances in imaging tools and theranostic agents. The review also addresses the importance of tailored imaging probes for sensitive and specific CXCR4-targeted immune cell imaging.

CANCERS (2021)

Add to Collection

Review Oncology

Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review

Melika Shirdarreh et al.

Summary: Patients show positive attitudes towards tumor NGS testing but lack adequate genetic knowledge, leading to unrealistic expectations. Oncologists have poor genomic literacy and face challenges in communicating with patients.

ONCOLOGIST (2021)

Add to Collection

Article Multidisciplinary Sciences

A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment

Jen-Shin Song et al.

Summary: BPRCX807, a safe, selective, and potent CXCR4 antagonist, significantly suppresses primary tumor growth, prevents distant metastasis/cell migration, reduces angiogenesis, and normalizes the immunosuppressive tumor microenvironment in hepatocellular carcinoma mouse models. When used in combination therapy with sorafenib and anti-PD-1, it synergistically prolongs overall survival and further suppresses distant metastasis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Oncology

Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA

Yanpeng Ding et al.

Summary: The expression of MT1L was decreased in BLCA, but it was positively correlated with immune cells such as Tregs and MDSCs, as well as with typical markers of immune cells like PD-1 and CTLA-4. High expression of MT1L was significantly associated with shorter overall survival times of BLCA patients, indicating that MT1L could be an independent prognostic factor in BLCA.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

The complex Integration of T-cell Metabolism and Immunotherapy

Matthew Z. Madden et al.

Summary: The metabolic reprogramming of T cells plays a crucial role in their function and fate, but is disrupted in cancer, potentially suppressing antitumor immunity. Therefore, stimulating effector T cell metabolism and enhancing cancer immunotherapy are challenges and opportunities that need to be addressed.

CANCER DISCOVERY (2021)

Add to Collection

Article Oncology

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer

Haoya Xu et al.

Summary: This study identified six MRPs related to HE4 in ovarian cancer, with MRPL15 being highly expressed and associated with poor prognosis. MRPL15 plays a role in ovarian cancer through pathways such as the cell cycle, DNA repair, and mTOR 1 signaling. High expression of MRPL15 in ovarian cancer may be associated with its amplification and hypomethylation, and it is correlated with the proliferation of CD8(+) T cells and dendritic cells in C3 ovarian cancer as well as the expression of TGF beta R1 and IDO1.

CANCER MEDICINE (2021)

Add to Collection

Review Immunology

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

Ken Maes et al.

Summary: Cancer cells can evade the immune system through epigenetic alterations, but epigenetic modulating agents have the potential to restore immunological fitness and overcome peripheral tolerance to transformed cells. By acting on both cancer cells and immune cells, EMAs represent interesting strategies for combinatorial therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Oncology

Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies

Anna Myriam Perrone et al.

Summary: Electrochemotherapy (ECT) is an emerging treatment for solid tumors that involves maximizing the action of specific cytotoxic drugs through the tumor-directed delivery of non-ablative electrical pulses. Despite mainly being recommended for palliative care, ECT has the potential to improve patient outcomes by preventing or delaying tumor progression. Additionally, the efficacy of different drugs in ECT, such as cisplatin and bleomycin, should be compared through systematic literature reviews to explore the possibilities of overcoming chemoresistance and improving local control.

CANCERS (2021)

Add to Collection

Review Oncology

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma

Lorraine N. Davis et al.

Summary: Multiple myeloma, a deadly blood cancer, has key drug classes for treatment including immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. Patients often develop multi-drug resistance, and understanding the mechanisms behind drug resistance in multi-relapsed patients is crucial for improving treatment strategies. Many new agents are being evaluated in preclinical and clinical trials to overcome or delay drug resistance, offering potential to extend patient lifespan.

CANCERS (2021)

Add to Collection

Article Oncology

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma

Tao Zhang et al.

Summary: This study constructed a classifier using Mito-RGs to predict the prognosis of HCC patients. The repression of primary bile acid biosynthesis was found to play a crucial role in the development and poor prognosis of HCC, and the study revealed the crosstalk between bile acid and immune cell infiltration in tumors.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Andrology

A narrative review of individualized treatments of genitourinary tumors: is the future brighter with molecular evaluations?

Francesca Giunchi et al.

Summary: Advancements have been made in the study of molecular diagnostic, prognostic, and predictive biomarkers in genitourinary tumors, with a focus on the impact of molecular changes on disease in the future.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy

Matte Kasi Viswanadh et al.

Summary: The study successfully synthesized a novel GSH redox-sensitive TPGH-SH and prepared drug carriers with nano-particle properties, where drug release was pH and GSH concentration dependent. The targeted formulation exhibited higher cytotoxicity and uptake in cells, potentially enhancing therapeutic efficacy.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Article Health Care Sciences & Services

Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

Matthew J. Page et al.

Summary: The study provides an overview of the processes used to update the PRISMA 2009 statement, including a survey of systematic review methodologists and journal editors, decisions made at the update meeting, and changes to the guideline.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Add to Collection

Article Pathology

Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma

Ning Wang et al.

Summary: This study identified that LOXL3 gene expression is upregulated in tumor tissues, positively correlated with multiple immune cell infiltrates and immune checkpoint gene expression in HCC, and associated with poor outcomes of HCC patients. Functional enrichment analysis revealed that LOXL3 is mainly involved in extracellular structure and matrix organization, cell-cell adhesion, and T cell activation, suggesting its potential as a novel biomarker for predicting prognosis and guiding immunotherapy in HCC.

VIRCHOWS ARCHIV (2021)

Add to Collection

Article Multidisciplinary Sciences

Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer

S. H. Petersen et al.

Summary: Surgery remains the primary treatment for gastric cancer, with immunotherapeutic tools slowly being implemented. The immune microenvironment in gastric cancer during treatment modalities is still poorly understood. Chemoradiation induces distinct responses in different gastric cancer cell lines, with immunogenic cell death observed and resistance mechanisms through upregulation of immunosuppressive proteins. Combination treatment using checkpoint inhibitors could potentially enhance immune responses and improve patient outcomes.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Cell Biology

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer

Xinglong Geng et al.

Summary: The roles of CAFs in PDAC are diverse, with different subtypes supporting or inhibiting cancer cell proliferation. As research progresses, CAFs may be a key factor in the treatment of pancreatic cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy

Juwon Lee et al.

Summary: The use of immune checkpoint inhibitors shows promise in cancer treatment but is hindered by severe immunogenic side effects and lack of response against many cancer types. Plant-derived natural compounds offer regulation on various signaling cascades and have the potential for cancer treatment. Studies have shown that some plant compounds can effectively modulate immune checkpoints in various cancers.

BIOMOLECULES (2021)

Add to Collection

Review Oncology

Colony Stimulating Factor-1 and its Receptor in Gastrointestinal Malignant Tumors

Hong-wu Li et al.

Summary: Gastrointestinal malignant tumors are among the most common types of cancer globally, with poor prognosis for advanced patients. Research on tumor microenvironment and cytokines has become a hotspot, with CSF-1/CSF-1R playing crucial roles in regulating tumor-associated macrophages. Targeted inhibition of the CSF-1/CSF-1R signal axis shows promising prospects in cancer immunotherapy.

JOURNAL OF CANCER (2021)

Add to Collection

Article Biochemistry & Molecular Biology

KEGG Mapper for inferring cellular functions from protein sequences

Minoru Kanehisa et al.

PROTEIN SCIENCE (2020)

Add to Collection

Article Engineering, Biomedical

Preparation of paclitaxel-folic acid functionalized gelatin grafted mesoporous hollow carbon nanospheres for enhancing antitumor effects toward liver cancer (SMMC-7721) cell lines

Yu Gao et al.

JOURNAL OF BIOMATERIALS APPLICATIONS (2020)

Add to Collection

Review Medicine, Research & Experimental

Role of the lysyl oxidase family in organ development (Review)

Shanzun Wei et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

Meta-Analysis

Adrian Hernandez et al.

CHEST (2020)

Add to Collection

Article Oncology

Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity

Jaewang Lee et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Add to Collection

Article Integrative & Complementary Medicine

The Mechanisms of Sijunzi Decoction in the Treatment of Chronic Gastritis Revealed by Network Pharmacology

Ting Wang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer

Hung-Yu Lin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Oncology

Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions

A. Weinmann et al.

CURRENT ONCOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase

Kazuo Noda et al.

SCIENCE ADVANCES (2020)

Add to Collection

Review Pharmacology & Pharmacy

Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy

Miaomiao Ye et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Derepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53

Jialiang Shao et al.

CELL DEATH AND DIFFERENTIATION (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting Tumor Microenvironment for Cancer Therapy

Catarina Roma-Rodrigues et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Oncology

Lysyl oxidase assists tumor-initiating cells to enhance angiogenesis in hepatocellular carcinoma

Min Yang et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis

Rongkun Li et al.

MOLECULAR CANCER (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin

Christian E. H. Schmelzer et al.

FASEB JOURNAL (2019)

Add to Collection

Review Immunology

Transforming Growth Factor-β Signaling in Immunity and Cancer

Eduard Batlle et al.

IMMUNITY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer

Dinh-Toi Chu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Medicine, Research & Experimental

Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review

Zhaoyang Tan

MEDICAL SCIENCE MONITOR (2019)

Add to Collection

Review Biochemistry & Molecular Biology

The Janus Face of Tumor Microenvironment Targeted by Immunotherapy

Maria Buoncervello et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets

Yujie Shen et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Add to Collection

Article Immunology

Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl4-induced liver fibrosis in rats

Roohollah Mohseni et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)

Add to Collection

Review Pharmacology & Pharmacy

The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial

Peter John et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Add to Collection

Article Medicine, General & Internal

Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts

Qing Li et al.

EBIOMEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development

Karolina Sterzynska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Cell Biology

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma

Bing Shao et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

New approach for understanding genome variations in KEGG

Minoru Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Damian Szklarczyk et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Review Oncology

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

Inaki Etxeberria et al.

ESMO OPEN (2019)

Add to Collection

Article Biochemistry & Molecular Biology

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Suhas V. Vasaikar et al.

NUCLEIC ACIDS RESEARCH (2018)

Add to Collection

Review Oncology

Emerging targets in cancer immunotherapy

Samantha Burugu et al.

SEMINARS IN CANCER BIOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking

Wenshan Zhao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Jianfang Liu et al.

CELL (2018)

Add to Collection

Article Oncology

Significance of Lysyl oxidase-like 2 gene expression on the epithelial-mesenchymal status of hepatocellular carcinoma

Go Ninomiya et al.

ONCOLOGY REPORTS (2018)

Add to Collection

Review Immunology

Tissue-Dependent Tumor Microenvironments and Their impact on immunotherapy Responses

Amanda J. Oliver et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer

Hiroaki Kasashima et al.

DIGESTION (2018)

Add to Collection

Article Genetics & Heredity

Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals

Shicheng Li et al.

GENE (2018)

Add to Collection

Article Oncology

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

Davide Melisi et al.

BRITISH JOURNAL OF CANCER (2018)

Add to Collection

Article Biochemistry & Molecular Biology

KEGG: new perspectives on genomes, pathways, diseases and drugs

Minoru Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Review Immunology

New checkpoints in cancer immunotherapy

Ling Ni et al.

IMMUNOLOGICAL REVIEWS (2017)

Add to Collection

Review Rheumatology

Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases

Michael Croft et al.

NATURE REVIEWS RHEUMATOLOGY (2017)

Add to Collection

Article Oncology

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis

Franco Conforti et al.

ONCOTARGET (2017)

Add to Collection

Article Cell & Tissue Engineering

Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes

Aline Lopes Ribeiro et al.

STEM CELLS INTERNATIONAL (2017)

Add to Collection

Article Oncology

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Darshan S. Chandrashekar et al.

NEOPLASIA (2017)

Add to Collection

Article Oncology

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells

Taiwen Li et al.

CANCER RESEARCH (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Lysyl Oxidase: Its Diversity in Health and Diseases

Suchitra Kumari et al.

INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2017)

Add to Collection

Review Oncology

Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

J. M. Pitt et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Review Genetics & Heredity

Advancements in Next-Generation Sequencing

Shawn E. Levy et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 17 (2016)

Add to Collection

Review Oncology

4-1BB agonism: adding the accelerator to cancer immunotherapy

Cariad Chester et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)

Add to Collection

Article Medicine, General & Internal

The Epidemiological Investigation on the Risk Factors of Hepatocellular Carcinoma A Case-Control Study in Southeast China

Jianjun Niu et al.

MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery

Annacarmen Petrizzo et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Biotechnology & Applied Microbiology

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Bo Li et al.

GENOME BIOLOGY (2016)

Add to Collection

Article Medicine, Research & Experimental

Meta-analysis in clinical trials revisited

Rebecca DerSimonian et al.

CONTEMPORARY CLINICAL TRIALS (2015)

Add to Collection

Article Gastroenterology & Hepatology

Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma

Jiye Zhu et al.

DIGESTIVE DISEASES AND SCIENCES (2015)

Add to Collection

Article Medicine, Research & Experimental

Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

Bryan W. Miller et al.

EMBO MOLECULAR MEDICINE (2015)

Add to Collection

Review Oncology

Nomograms in oncology: more than meets the eye

Vinod P. Balachandran et al.

LANCET ONCOLOGY (2015)

Add to Collection

Review Oncology

B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?

P. J. Hengeveld et al.

BLOOD CANCER JOURNAL (2015)

Add to Collection

Article Chemistry, Medicinal

A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma

Fei Hu et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2015)

Add to Collection

Article Multidisciplinary Sciences

Origin and evolution of lysyl oxidases

Xavier Grau-Bove et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Review Gastroenterology & Hepatology

The evolving epidemiology of hepatocellular carcinoma: a global perspective

Michael C. Wallace et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)

Add to Collection

Article Biochemical Research Methods

Novel function discovery with GeneMANIA: a new integrated resource for gene function prediction in Escherichia coli

James Vlasblom et al.

BIOINFORMATICS (2015)

Add to Collection

Article Oncology

First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

Jordi Rodon et al.

CLINICAL CANCER RESEARCH (2015)

Add to Collection

Article Biochemistry & Molecular Biology

A new role for LOX and LOXL2 proteins in transcription regulation

Ane Iturbide et al.

FEBS JOURNAL (2015)

Add to Collection

Article Gastroenterology & Hepatology

Lysyl Oxidase-Like 2 Is Critical to Tumor Microenvironment and Metastatic Niche Formation in Hepatocellular Carcinoma

Carmen Chak-Lui Wong et al.

HEPATOLOGY (2014)

Add to Collection

Article Oncology

Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape

Ana C. Anderson

CANCER IMMUNOLOGY RESEARCH (2014)

Add to Collection

Editorial Material Pediatrics

What is next generation sequencing?

Sam Behjati et al.

ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Add to Collection

Article Oncology

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

Douglas Hanahan et al.

CANCER CELL (2012)

Add to Collection

Article Genetics & Heredity

Diagnostic Interpretation of Array Data Using Public Databases and Internet Sources

Nicole de Leeuw et al.

HUMAN MUTATION (2012)

Add to Collection

Article Oncology

Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer Metastasis

Qian Xiao et al.

CANCER MICROENVIRONMENT (2012)

Add to Collection

Article Pharmacology & Pharmacy

Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer

Wan-Wan Lin et al.

BIOCHEMICAL PHARMACOLOGY (2011)

Add to Collection

Review Cell Biology

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

Thomas R. Cox et al.

DISEASE MODELS & MECHANISMS (2011)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra V. Navarra et al.

LANCET (2011)

Add to Collection

Review Oncology

Liver cancer epidemic in China: Past, present and future

Jian Guo Chen et al.

SEMINARS IN CANCER BIOLOGY (2011)

Add to Collection

Review Cardiac & Cardiovascular Systems

Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects

Begona Lopez et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor

Hector M. Rodriguez et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Add to Collection

Editorial Material Rheumatology

IMMUNOLOGY TL1A in the inflammatory network in autoimmune diseases

Jagadeesh Bayry

NATURE REVIEWS RHEUMATOLOGY (2010)

Add to Collection

Article Mathematical & Computational Biology

A basic introduction to fixed-effect and random-effects models for meta-analysis

Michael Borenstein et al.

RESEARCH SYNTHESIS METHODS (2010)

Add to Collection

Article Oncology

NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway

Grant D. Stewart et al.

INTERNATIONAL JOURNAL OF CANCER (2009)

Add to Collection

Article Biochemical Research Methods

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Da Wei Huang et al.

NATURE PROTOCOLS (2009)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Da Wei Huang et al.

NUCLEIC ACIDS RESEARCH (2009)

Add to Collection

Review Immunology

The role of TNF superfamily members in T-cell function and diseases

Michael Croft

NATURE REVIEWS IMMUNOLOGY (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells

Hector A. Lucero et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection

Article Oncology

How to build and interpret a nomogram for cancer prognosis

Alexia Iasonos et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Add to Collection

Article Critical Care Medicine

Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited

Andrew A. Kramer et al.

CRITICAL CARE MEDICINE (2007)

Add to Collection

Review Oncology

Lysyl oxidase mediates hypoxic control of metastasis

Janine T. Erler et al.

CANCER RESEARCH (2006)

Add to Collection

Article Oncology

TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

DA Thomas et al.

CANCER CELL (2005)

Add to Collection

Article Biochemistry & Molecular Biology

Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation

B Fogelgren et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Article Oncology

Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action

CR Yang et al.

CANCER RESEARCH (2004)

Add to Collection

Article Mathematical & Computational Biology

Overall C as a measure of discrimination in survival analysis:: model specific population value and confidence interval estimation

MJ Pencina et al.

STATISTICS IN MEDICINE (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and functional diversity of lysyl oxidase and the LOX-like proteins

J Molnar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2003)

Add to Collection

Article Mathematical & Computational Biology

Quantifying heterogeneity in a meta-analysis

JPT Higgins et al.

STATISTICS IN MEDICINE (2002)

Add to Collection

Article Biochemistry & Molecular Biology

A novel secreted splice variant of vascular endothelial cell growth inhibitor

LJ Chew et al.

FASEB JOURNAL (2002)

Add to Collection

Review Immunology

Differential evolutionary NMC class II strategies in humans and rhesus macaques: relevance for biomedical studies

GGM Doxiadis et al.

IMMUNOLOGICAL REVIEWS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.